Skip to main content
. Author manuscript; available in PMC: 2021 Apr 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2019 Mar 20;83(6):1025–1035. doi: 10.1007/s00280-019-03805-6

Figure 1. Progression-Free Survival in Months from Consent Date.

Figure 1.

Progression-free survival probability from the date consent was obtained. The median progression-free survival and the 95% confidence interval are noted. The number censored and uncensored values are noted in the table below the graph.